Exciting and important work happening at MD Anderson. "Through its work, IDSO not only allows for better analysis of existing data but also changes how MD Anderson generates, collects and manages data. This comprehensive approach enables research and clinical teams to derive new and deeper insights that can be applied to accelerate drug discovery and development, to improve scheduling and access for patients, to enhance the safety and quality of care, and to allow for personalized treatment decisions based on results and predictions from diagnostic tests."
Today, we announce the launch of our Institute for Data Science in Oncology. “At MD Anderson, we are intimately familiar with the urgent needs and challenges facing our patients, and we will find the best solutions possible by unlocking the full power of the growing and increasingly complex data,” says our Dr. Caroline Chung. Learn more about it here: https://bit.ly/474qwid #EndCancer